These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 22998665)
21. Structural basis for the inhibition of truncated islet amyloid polypeptide aggregation by Cu(II): insights into the bioinorganic chemistry of type II diabetes. Rivillas-Acevedo L; Sánchez-López C; Amero C; Quintanar L Inorg Chem; 2015 Apr; 54(8):3788-96. PubMed ID: 25826050 [TBL] [Abstract][Full Text] [Related]
22. Sensitivity of amyloid formation by human islet amyloid polypeptide to mutations at residue 20. Cao P; Tu LH; Abedini A; Levsh O; Akter R; Patsalo V; Schmidt AM; Raleigh DP J Mol Biol; 2012 Aug; 421(2-3):282-95. PubMed ID: 22206987 [TBL] [Abstract][Full Text] [Related]
23. (-)-epigallocatechin-3-gallate (EGCG) maintains kappa-casein in its pre-fibrillar state without redirecting its aggregation pathway. Hudson SA; Ecroyd H; Dehle FC; Musgrave IF; Carver JA J Mol Biol; 2009 Sep; 392(3):689-700. PubMed ID: 19616561 [TBL] [Abstract][Full Text] [Related]
24. Epigallocatechin gallate (EGCG) reduces the intensity of pancreatic amyloid fibrils in human islet amyloid polypeptide (hIAPP) transgenic mice. Franko A; Rodriguez Camargo DC; Böddrich A; Garg D; Rodriguez Camargo A; Rathkolb B; Janik D; Aichler M; Feuchtinger A; Neff F; Fuchs H; Wanker EE; Reif B; Häring HU; Peter A; Hrabě de Angelis M Sci Rep; 2018 Jan; 8(1):1116. PubMed ID: 29348618 [TBL] [Abstract][Full Text] [Related]
25. Role of Site-Specific Asparagine Deamidation in Islet Amyloid Polypeptide Amyloidogenesis: Key Contributions of Residues 14 and 21. Nguyen PT; Zottig X; Sebastiao M; Bourgault S Biochemistry; 2017 Jul; 56(29):3808-3817. PubMed ID: 28665109 [TBL] [Abstract][Full Text] [Related]
26. Analysis of the Amyloidogenic Potential of Pufferfish (Takifugu rubripes) Islet Amyloid Polypeptide Highlights the Limitations of Thioflavin-T Assays and the Difficulties in Defining Amyloidogenicity. Wong AG; Wu C; Hannaberry E; Watson MD; Shea JE; Raleigh DP Biochemistry; 2016 Jan; 55(3):510-8. PubMed ID: 26694855 [TBL] [Abstract][Full Text] [Related]
27. Nonhuman IAPP Variants Inhibit Human IAPP Aggregation. Oakes A; Menefee K; Lamba A; Palato LM; Rinauro DJ; Tun A; Jauregui B; Chang K; Nogaj LA; Moffet DA Protein Pept Lett; 2021; 28(9):963-971. PubMed ID: 34365921 [TBL] [Abstract][Full Text] [Related]
28. Dissecting the role of single regions of an IAPP mimic and IAPP in inhibition of Aβ40 amyloid formation and cytotoxicity. Andreetto E; Yan LM; Caporale A; Kapurniotu A Chembiochem; 2011 Jun; 12(9):1313-22. PubMed ID: 21630409 [TBL] [Abstract][Full Text] [Related]
29. Overall sulfation of heparan sulfate from pancreatic islet β-TC3 cells increases maximal fibril formation but does not determine binding to the amyloidogenic peptide islet amyloid polypeptide. Hull RL; Peters MJ; Perigo SP; Chan CK; Wight TN; Kinsella MG J Biol Chem; 2012 Oct; 287(44):37154-64. PubMed ID: 22936797 [TBL] [Abstract][Full Text] [Related]
30. IAPP aggregation and cellular toxicity are inhibited by 1,2,3,4,6-penta-O-galloyl-β-D-glucose. Bruno E; Pereira C; Roman KP; Takiguchi M; Kao PY; Nogaj LA; Moffet DA Amyloid; 2013 Mar; 20(1):34-8. PubMed ID: 23339420 [TBL] [Abstract][Full Text] [Related]
31. Interaction between amyloid beta peptide and an aggregation blocker peptide mimicking islet amyloid polypeptide. Rezaei-Ghaleh N; Andreetto E; Yan LM; Kapurniotu A; Zweckstetter M PLoS One; 2011; 6(5):e20289. PubMed ID: 21633500 [TBL] [Abstract][Full Text] [Related]
32. Does deamidation affect inhibitory mechanisms towards amyloid protein aggregation? Lam YPY; Chiu CKC; Wootton CA; Hands-Portman I; Li M; Barrow MP; O'Connor PB Chem Commun (Camb); 2020 Aug; 56(68):9787-9790. PubMed ID: 32748913 [TBL] [Abstract][Full Text] [Related]
33. Protein Glycation by Glyoxal Promotes Amyloid Formation by Islet Amyloid Polypeptide. Hsu YH; Chen YW; Wu MH; Tu LH Biophys J; 2019 Jun; 116(12):2304-2313. PubMed ID: 31155148 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of membrane models and their composition for islet amyloid polypeptide-membrane aggregation. Caillon L; Lequin O; Khemtémourian L Biochim Biophys Acta; 2013 Sep; 1828(9):2091-8. PubMed ID: 23707907 [TBL] [Abstract][Full Text] [Related]
35. Membrane Curvature-sensing and Curvature-inducing Activity of Islet Amyloid Polypeptide and Its Implications for Membrane Disruption. Kegulian NC; Sankhagowit S; Apostolidou M; Jayasinghe SA; Malmstadt N; Butler PC; Langen R J Biol Chem; 2015 Oct; 290(43):25782-93. PubMed ID: 26283787 [TBL] [Abstract][Full Text] [Related]
39. Rational design of potent domain antibody inhibitors of amyloid fibril assembly. Ladiwala AR; Bhattacharya M; Perchiacca JM; Cao P; Raleigh DP; Abedini A; Schmidt AM; Varkey J; Langen R; Tessier PM Proc Natl Acad Sci U S A; 2012 Dec; 109(49):19965-70. PubMed ID: 23161913 [TBL] [Abstract][Full Text] [Related]
40. Direct measurement of islet amyloid polypeptide fibrillogenesis by mass spectrometry. Larson JL; Ko E; Miranker AD Protein Sci; 2000 Feb; 9(2):427-31. PubMed ID: 10716196 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]